Evidence map›Paper›PMID 22085974›Full record

ArticleThe American journal of pathology2012

TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation.

Holly R Chinnery, Samuel McLenachan, Nicolette Binz, Yan Sun, John V Forrester, Mariapia A Degli-Esposti, Eric Pearlman, Paul G McMenamin

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Genetic Models of Macrophage Depletion.Methods in molecular biology (Clifton, N.J.) · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. The role of Toll-like receptors in retinal ischemic diseases.International journal of ophthalmology · 2016
    Review
  13. Article
  14. Article
  15. Article
  16. Wounding the cornea to learn how it heals.Experimental eye research · 2014
    Review
  17. The Immune System and AMD.Current ophthalmology reports · 2014
    Article
  18. Article
  19. Article
  20. Host defense at the ocular surface.International reviews of immunology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Holly R ChinneryDepartment of Anatomy and Developmental Biology, School of Biomedical Sciences, Monash University, Clayton, VIC, Australia.
Samuel McLenachan
Nicolette Binz
Yan Sun
John V Forrester
Mariapia A Degli-Esposti
Eric Pearlman
Paul G McMenamin
Lions Eye Institute · AUCase Western Reserve University · USUniversity of Aberdeen · GBUniversity of Western Australia · AU

Funding

Toll Like Receptors in Bacterial KeratitisR01EY014362 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI GEORGE R DUBYAK, Eric Pearlman · 2003 to 2026
$8.7M
NEI NIH HHS R01 EY014362NEI NIH HHS R01 EY14362
6 · The paper itself

Abstract

During bacterial and viral infections, unmethylated CpG-DNA released by proliferating and dying microbes is recognized by toll-like receptor (TLR) 9 in host cells, initiating innate immune responses. Many corneal infections occur secondary to epithelial breaches and represent a major cause of vision impairment and blindness globally. To mimic this clinical situation, we investigated mechanisms of TLR9 ligand-induced corneal inflammation in mice after epithelial debridement. Application of CpG oligodeoxynucleotides (ODNs) resulted in neutrophil and macrophage infiltration to the cornea and loss of transparency. By 6 hours after CpG-ODN administration, TLR9 mRNA was increased in the cornea and retina. In vivo clinical examination at 24 hours revealed inflammatory infiltrates in the vitreous and retina, which were confirmed ex vivo to be neutrophils and macrophages, along with activated resident microglia. CpG-ODN-induced intraocular inflammation was abrogated in TLR9(-/-) and macrophage-depleted mice. Bone marrow reconstitution of irradiated TLR9(-/-) mice with TLR9(+/+) bone marrow led to restored corneal inflammatory responses to CpG-ODN. Fluorescein isothiocyanate-CpG-ODN rapidly penetrated the cornea and ocular media to reach the retina, where it was present within CD68(+) retinal macrophages and microglia. These data show that topically applied CpG-ODN induces intraocular inflammation owing to TLR9 activation of monocyte-lineage cells. These novel findings indicate that microbial CpG-DNA released during bacterial and/or viral keratitis can cause widespread inflammation within the eye, including the retina.

Indexed as

Corneal InjuriesAdjuvants, ImmunologicAnimalsCorneaImmunity, InnateKeratitisLipopolysaccharidesMacrophagesMiceMice, Inbred BALB CMice, Inbred C57BLNeutrophil InfiltrationOligodeoxyribonucleotidesRetinitisToll-Like Receptor 4Toll-Like Receptor 9Adjuvants, ImmunologicCPG-oligonucleotideLipopolysaccharidesOligodeoxyribonucleotidesToll-Like Receptor 4Toll-Like Receptor 9

Identifiers

PMID22085974
PMCPMC3338340
OpenAlexW2005818840

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.